About Technology Review. Technology Review, Inc., an MIT Enterprise, delivers essential information about emerging technologies on the verge of commercialisation. Since 1998, paid circulation for the company's magazine, Technology Review, has more than tripled, climbing from 92,000 to 315,000. Combined with its signature events, newsletters, and online businesses, Technology Review reaches over a million senior technology thinkers and influencers including venture capitalists, chief scientists, MIT alumni and students, researchers, senior corporate executives, investors, and innovators throughout the world each month.
About The Scripps Research Institute. The Scripps Research Institute is one of the largest, private, non-profit scientific research organizations in the world. It stands at the forefront of basic biomedical science, a vital segment of medical research that seeks to comprehend the most fundamental processes of life, and is recognized for its research in molecular and cellular biology, chemistry, immunology, the neurosciences, and molecular medicine.
*************************************************************************
The cutting edge of medical research is Glycobiology.
Mannatech is actually years AHEAD of the research, because Mannatech ALREADY has this incredible world changing technology available NOW, in a practical form that is helping people NOW.
Research is wonderful and exciting, but it does NOTHING for suffering right now.
RESULTS are always superior to research.
Mannatech is far beyond the cutting edge RESEARCH, RESULTS are being provided for people NOW, and we OWE it to everyone we know to tell them that they don’t have to wait 10 years for the expensive and probably toxic glyco-based drugs.
Most people don’t yet have an appreciation for the phenomenal gift you have to offer, but don’t let that stop you. Too much is at stake.
Tell everyone as if their life depended upon it, it probably does...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment